Trademarkia Logo

Canada

C$
SII
REGISTERED

on 25 Oct 2023

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

SERUM INSTITUTE OF INDIA PRIVATE LIMITED

Sarosh Bhavan, 16-B/1,Dr. Ambedkar RoadPune-411001

IN

Serial Number

2099627 filed on 26th Nov 2020

Registration Number

TMA1204958 registered on 25th Oct 2023

Registration expiry Date

26th Nov 2030

Correspondent Address

DEETH WILLIAMS WALL LLP

150 YORK STREET, SUITE 400TORONTO

ONTARIO

CA

M5H3S5

SII

Trademark usage description

medicinal and pharmaceutical preparations, namely, human vaccine preparations, anti-toxins in the nature of tetanus vaccines, antivenom, vaccines agai Read More

Vienna Information


26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 18

Circles or ellipses containing one or more lettersCercles ou ellipses contenant une ou plusieurs lettres

Classification Information


Class [005]
Medicinal and pharmaceutical preparations, namely, human vaccine preparations, anti-toxins in the nature of tetanus vaccines, antivenom, vaccines against Diphtheria, Tetanus and Pertussis, vaccines against measles, mumps and rubella, vaccines against Hepatitis B, vaccines against polio, vaccines against pneumococcal infections, tuberculosis, and influenza, vaccines against coronavirus, vaccines against human papillomavirus, vaccines against rabies, vaccines against monkey pox, pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders, pharmaceutical preparations for the treatment of hormonal disorders, namely, infertility, hyperprolactinemia, pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely, premenstrual syndrome, menstrual pain, premenstrual tension, endometriosis, menorrhagia, gynaecomastia, secondary amenorrhoea, infertility, uterine fibroids, precocious puberty, pharmaceutical preparations for the treatment of benign fibrocystic breast disease, pharmaceutical preparations for the prevention and treatment of iron deficiency and anaemia in humans, pharmaceutical preparations for the treatment of kidney diseases and disorders, pharmaceutical preparations for the treatment of flat urothelial cell carcinoma in situ (CIS) of the bladder, pharmaceutical preparations for the treatment of prostate cancer, pharmaceutical preparations for the treatment of genitourinary and pelvic diseases, disorders and infections, namely, benign prostatic hypertrophy, pharmaceutical preparations for the relief of pain, pharmaceutical preparations for the treatment of arthritis, muscle soreness and sprains, pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibroids, and cirrhosis, pharmaceutical preparations for the treatment of diabetic neuropathy, diarrhoea medication, pharmaceutical preparations for the prevention of osteoporosis, pharmaceutical preparations for the treatment of osteoporosis, calcium supplements, pharmaceutical preparations for the prevention of nausea and vomiting during pregnancy, pharmaceutical preparations for the treatment of fever, pharmaceutical cold preparations, dietary supplements consisting of vitamins, amino acids, fatty acids, minerals and trace elements, pharmaceutical hormonal preparations, namely, hormone replacement therapy preparations, oral contraceptives, pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infection, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria, alopecia areata, dermatitis, and eczema.


Classification kind code

11

Mark Details


Serial Number

2099627

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 2th Jun 2023
Agent Changed
Submitted for opposition 22
on 8th Aug 2022
Search Recorded
Submitted for opposition 20
on 8th Aug 2022
Examiner's First Report
Submitted for opposition 223
on 8th Aug 2022
Total Provisional Refusal
Submitted for opposition 256
on 15th Feb 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 15th Apr 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 14th Apr 2021
Created
Submitted for opposition 31
on 14th Apr 2021
Formalized
Submitted for opposition 30
on 26th Nov 2020
Filed
Submitted for opposition 228
on 26th Nov 2020
International Registration